ALMKT:EPA
Mauna Kea Technologies SA
€ 0,091
arrow_downward
-1,62%(-0,0015) 1D
6 de nov., 17:35:04 GMT+1 · EUR
search
Todos os ativos
| Códigos | Preço | Variação | % de variação |
|---|
insights_autoGerando os principais insights para ALMKT…
Abrir
€ 0,08
Alta
€ 0,09
Baixa
€ 0,08
Valor de mercado
18,26 mi
Volume médio
549,48 mil
Volume
385,57 mil
Índice P/L
0,78
Alto — 52 sem
€ 0,23
Baixo — 52 sem
€ 0,07
LPA
€ 0,12
Ações em circulação
195,26 mi
Nº de funcionários
56
Abrir
€ 0,08
Alta
€ 0,09
Baixa
€ 0,08
Valor de mercado
18,26 mi
Volume médio
549,48 mil
Volume
385,57 mil
Índice P/L
0,78
Alto — 52 sem
€ 0,23
Baixo — 52 sem
€ 0,07
LPA
€ 0,12
Ações em circulação
195,26 mi
Nº de funcionários
56
Notícias
De fontes da web e parceiros de notícias
Yahoo Finance
·
há 2 horas
S&P 500 warning signal persists as tech stocks weaken
MarketWatch
·
há 59 minutos
Opinion: The S&P 500 could be dangerously exposed to AI. Here are some simple alternatives.
Barron's
·
há 5 horas
S&P 500 Futures Rise in Premarket Trading; JFrog, Cloudflare Lead
Perfil
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
Sobre Mauna Kea Technologies SA